Drug targeting of heme proteins ion Mycobacterium tuberculosis

被引:17
|
作者
McLean, Kirsty J. [1 ]
Munro, Andrew W. [1 ]
机构
[1] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, 131 Princess St, Manchester M1 7DN, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
CHOLESTEROL CATABOLIC PATHWAY; CATALASE-PEROXIDASE GENE; CELL-WALL; TRUNCATED HEMOGLOBIN; TRANSCRIPTIONAL REGULATION; ISONIAZID RESISTANCE; CYP121; INHIBITORS; MEMBRANE-PROTEINS; IRON-METABOLISM; KATG EXPRESSION;
D O I
10.1016/j.drudis.2016.11.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
TB, caused by the human pathogen Mycobacterium tuberculosis (Mtb), causes more deaths than any other infectious disease. Iron is crucial for Mtb to infect the host and to sustain infection, with Mtb encoding large numbers of iron-binding proteins. Many of these are hemoproteins with key roles, including defense against oxidative stress, cellular signaling and regulation, host cholesterol metabolism, and respiratory processes. Various heme enzymes in Mtb are validated drug targets and/or products of genes essential for bacterial viability or survival in the host. Here, we review the structure, function, and druggability of key Mtb heme enzymes and strategies used for their inhibition.
引用
收藏
页码:566 / 575
页数:10
相关论文
共 50 条
  • [21] DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS
    Alorainy, Mohammad S.
    BULLETIN OF PHARMACEUTICAL SCIENCES, 2010, 33 : 235 - 240
  • [22] Targeting the Histidine Pathway in Mycobacterium tuberculosis
    Lunardi, Juleane
    Nunes, Jose Eduardo S.
    Bizarro, Cristiano V.
    Basso, Luiz Augusto
    Santos, Diogenes Santiago
    Machado, Pablo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (22) : 2866 - 2884
  • [23] Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis
    Anurag, Meenakshi
    Dash, Debasis
    MOLECULAR BIOSYSTEMS, 2009, 5 (12) : 1752 - 1757
  • [24] Transport mechanism of Mycobacterium tuberculosis MmpL/S family proteins and implications in pharmaceutical targeting
    Ma, Shuang
    Huang, Yu
    Xie, Fuling
    Gong, Zhen
    Zhang, Yuan
    Stojkoska, Andrea
    Xie, Jianping
    BIOLOGICAL CHEMISTRY, 2020, 401 (03) : 331 - 348
  • [25] Insights into binding and degradation of heme by Mycobacterium tuberculosis MhuD
    Thakuri, Biswash
    Graves, Amanda
    Chao, Alex
    Johansen, Sommer
    Goulding, Celia
    Liptak, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [26] Mycobacterium tuberculosis Can Utilize Heme as an Iron Source
    Jones, Christopher M.
    Niederweis, Michael
    JOURNAL OF BACTERIOLOGY, 2011, 193 (07) : 1767 - 1770
  • [27] Suppressing Mycobacterium tuberculosis virulence and drug resistance by targeting Eis protein through computational drug discovery
    Kumar, Geethu S.
    Sahoo, Amaresh Kumar
    Ranjan, Nishant
    Dwivedi, Vivek Dhar
    Agrawal, Sharad
    MOLECULAR DIVERSITY, 2025, 29 (02) : 1697 - 1723
  • [28] Comparative analyses of the proteins from Mycobacterium tuberculosis and human genomes: Identification of potential tuberculosis drug targets
    Sridhar, Settu
    Dash, Pallabini
    Guruprasad, Kunchur
    GENE, 2016, 579 (01) : 69 - 74
  • [29] Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems
    McLean, Kirsty J.
    Dunford, Adrian J.
    Neeli, Rajasekhar
    Driscoll, Max D.
    Munro, Andrew W.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 464 (02) : 228 - 240
  • [30] Structure-based drug design targeting the malty sweet Mycobacterium tuberculosis GlgE
    Petit, Cecile
    Kapil, Sunayana
    Veleti, Kumar
    Lindenberger, Jared
    Sucheck, Steven J.
    Ronning, Donald R.
    FASEB JOURNAL, 2018, 32 (01):